NHI
National Health Investors Inc
64.60$
+1.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.4% | -0.4% | 0.0% | -0.7% | +6.3% | +6.4% | -3.1% | -0.2% | +4.0% | +3.3% | +2.6% | |
| – | +201.8% | +1.1% | -3.9% | -2.0% | +11.2% | +27.6% | -26.3% | +2.1% | -18.6% | +5.8% | -4.2% | |
| – | +34.8% | -49.2% | +30.0% | +5.3% | +56.2% | +455.8% | -86.2% | +337.9% | -76.0% | +27.1% | +21.8% | |
| – | +34.8% | -49.2% | +30.0% | +5.3% | +56.2% | +455.8% | -86.2% | +337.9% | -76.0% | +27.1% | +21.8% | |
| – | +289.5% | +4.5% | -5.3% | -2.4% | +11.0% | -2.2% | -2.3% | -15.4% | -3.0% | +3.2% | -30.2% | |
| – | +1.0% | -100.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +5.5% | +2.7% | +2.0% | -0.6% | +7.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | +3.0% | -3.8% | |
| – | -0.3% | -0.3% | +0.2% | -0.1% | +1.4% | +8.9% | -10.4% | -0.6% | +5.5% | +8.0% | +1.8% | |
| – | +173.7% | -1.4% | +0.7% | +22.8% | +4.8% | +26.1% | -12.4% | -60.1% | -31.5% | +217.3% | +34.6% | |
| – | +389.0% | +1.4% | -1.6% | +30.5% | +3.8% | +35.0% | -15.5% | -73.5% | +25.0% | +147.2% | +41.7% | |
| – | +57.2% | -21.9% | +24.0% | -2.1% | +16.1% | -22.7% | +13.2% | +4.9% | +26.2% | -13.5% | +22.7% | |
| – | -0.8% | +0.4% | -0.3% | -28.1% | -0.3% | +0.1% | -9.2% | +36.2% | -4.9% | +0.1% | -12.9% | |
| – | -0.5% | -0.5% | -0.3% | -1.2% | +11.2% | +4.4% | +3.7% | +0.1% | +2.7% | -0.4% | +3.7% | |
| – | +1.3% | +1.3% | +1.4% | +1.1% | +1.7% | +1.3% | +1.4% | +1.2% | -114.8% | – | -114.2% | |
| – | +0.0% | +0.1% | +0.3% | +1.0% | +3.3% | +1.0% | +2.1% | +1.7% | -1.2% | +3.2% | -0.1% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.